A novel deep learning system for STEMI prognostic prediction from multi-sequence cardiac magnetic resonance

ST-elevation myocardial infarction (STEMI) remains a leading cause of cardiovascular morbidity and mortality worldwide, and accurate early risk stratification is critical for implementing precision therapies in clinical practice. However, existing clinical risk scores and manually derived imaging biomarkers have limited accuracy in predicting post-STEMI outcomes. To address this gap, we developed DeepSTEMI, an end-to-end deep learning system that integrates multi-sequence cardiac magnetic resonance (CMR) images with clinical parameters for predicting 2-year major adverse cardiovascular events (MACE). The system comprised two key algorithmic modules: a U-Net module that automatically segments heart regions from raw CMR images and a Transformer-based module that predicted future cardiovascular events. DeepSTEMI was developed using a multicenter dataset (n = 610; 20,618 images) from STEMI patients enrolled in the EARLY-MYO-CMR registry (NCT03768453), with external validation performed in 334 patients (9944 images) from three independent cardiac centers. In external validation, DeepSTEMI demonstrated superior predictive performance compared to conventional clinical risk scores and manual CMR parameters (AUC 0.894, 95% CI: 0.823-0.965; overall accuracy 94.3%). The model identified high-risk patients who exhibited a 20-fold MACE risk compared to low-risk counterparts (HR 20.43, log-rank P < 0.001). SHapley Additive exPlanations (SHAP) analysis revealed that DeepSTEMI's predictive power stems from clinical-imaging synergy, enabling it to capture complex pathological patterns. DeepSTEMI achieved consistently superior performance over the Eitel score across all subgroups, with the greatest benefit observed in women (NRI 1.597) and in patients imaged 4-7 d post-STEMI (NRI 1.442). Overall, DeepSTEMI serves as an automated, scalable, and interpretable clinical copilot, which advances post-STEMI risk stratification beyond the limitations of current paradigms.

Authors

Institutions

Publication Details

Journal
Science Bulletin
Published
2025-11-20
DOI
https://doi.org/10.1016/j.scib.2025.11.027
Citations
9
Primary Topic
Cardiac Imaging and Diagnostics
Type
article
Field-Weighted Citation Impact
12.24
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A novel deep learning system for STEMI prognostic prediction from multi-sequence cardiac magnetic resonance

Lian‐Ming Wu, Bin Sheng, Ying‐Jia Xu, Weiwei Quan et al.
9 citations
Science Bulletin
Cardiac Imaging and Diagnostics
12.24
article

A novel deep learning system for STEMI prognostic prediction from multi-sequence cardiac magnetic resonance

Lian‐Ming Wu, Bin Sheng, Ying‐Jia Xu, Weiwei Quan, Yu‐Min Sun, Zhengyu Tao, Yina Wu, Hongwei Ji, Ao Shi, Ke Peng, Yu Lin Zhong, Hongyi Xin, Yezi Chai, Dan Liu, Qiming Liu, Xu Wang, Xinli Li, Jun Pu, Meng Jiang, Sheng Chen, Keran Li, Wei Zhang, Hang Zhao, Yuanyuan Tian, Yuyan Lyu, Shengxian Tu, Chao Xia, Heng Ge, Yang Liu, Fuhua Yan, Yufei Wang, Yi‐Fan Chen
article en
9 citations

Abstract

ST-elevation myocardial infarction (STEMI) remains a leading cause of cardiovascular morbidity and mortality worldwide, and accurate early risk stratification is critical for implementing precision therapies in clinical practice. However, existing clinical risk scores and manually derived imaging biomarkers have limited accuracy in predicting post-STEMI outcomes. To address this gap, we developed DeepSTEMI, an end-to-end deep learning system that integrates multi-sequence cardiac magnetic resonance (CMR) images with clinical parameters for predicting 2-year major adverse cardiovascular events (MACE). The system comprised two key algorithmic modules: a U-Net module that automatically segments heart regions from raw CMR images and a Transformer-based module that predicted future cardiovascular events. DeepSTEMI was developed using a multicenter dataset (n = 610; 20,618 images) from STEMI patients enrolled in the EARLY-MYO-CMR registry (NCT03768453), with external validation performed in 334 patients (9944 images) from three independent cardiac centers. In external validation, DeepSTEMI demonstrated superior predictive performance compared to conventional clinical risk scores and manual CMR parameters (AUC 0.894, 95% CI: 0.823-0.965; overall accuracy 94.3%). The model identified high-risk patients who exhibited a 20-fold MACE risk compared to low-risk counterparts (HR 20.43, log-rank P < 0.001). SHapley Additive exPlanations (SHAP) analysis revealed that DeepSTEMI's predictive power stems from clinical-imaging synergy, enabling it to capture complex pathological patterns. DeepSTEMI achieved consistently superior performance over the Eitel score across all subgroups, with the greatest benefit observed in women (NRI 1.597) and in patients imaged 4-7 d post-STEMI (NRI 1.442). Overall, DeepSTEMI serves as an automated, scalable, and interpretable clinical copilot, which advances post-STEMI risk stratification beyond the limitations of current paradigms.

Science BulletinVol. 70(24)
University of Shanghai for Science and Technology (CN), Shanghai Jiao Tong University (CN), Renji Hospital (CN), Ruijin Hospital (CN), Jinshan Hospital of Fudan University (CN), Tsinghua University (CN)
Openalex Percentile: Top 1%
Cardiac Imaging and Diagnostics
12.24
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.